✦ LIBER ✦

A serotonin 5-HT1A receptor agonist prevents behavioral sensitization to l-DOPA in a rodent model of Parkinson's disease

✍ Scribed by Masahiko Tomiyama; Tamaki Kimura; Tetsuya Maeda; Kazuya Kannari; Muneo Matsunaga; Masayuki Baba

Book ID: 116774625
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 433 KB
Volume: 52
Category: Article
ISSN: 0168-0102
DOI: 10.1016/j.neures.2005.03.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of serotonin 5-HT1A agonist in a

Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease

✍ William Bara-Jimenez; Francesco Bibbiani; Michael J. Morris; Tzvetelina Dimitrov 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

## Abstract Intermittent stimulation of striatal dopaminergic receptors seems to contribute to motor dysfunction in advanced Parkinson's disease (PD). With severe dopaminergic denervation, exogenous levodopa is largely decarboxylated to dopamine in serotonergic terminals. If 5‐HT1A autoreceptors re

5-HT1A receptor agonist-mediated protect

5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease

✍ Erwan Bezard; Irene Gerlach; Rosario Moratalla; Christian E. Gross; Reinhard Jor 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 454 KB

5-HT1A receptor stimulation and L-DOPA-i

5-HT1A receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: Bridging the gap between serotonergic and glutamatergic mechanisms

✍ Philippe Huot; Jonathan M. Brotchie 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 172 KB

TRK-820, a selective kappa opioid recept

TRK-820, a selective kappa opioid receptor agonist, could effectively ameliorate L-DOPA-induced dyskinesia symptoms in a rat model of Parkinson's disease

✍ Ken Ikeda; Satoru Yoshikawa; Takahiro Kurokawa; Natsumi Yuzawa; Kaoru Nakao; Hid 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 707 KB

Neuroprotective effect of L-DOPA co-admi

Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson’s disease

✍ Luigi F. Agnati; Giuseppina Leo; Anna-Valeria Vergoni; Emili Martı́nez; Jörg Hoc 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 198 KB

L-DOPA induced increases in brain uric a

L-DOPA induced increases in brain uric acid in an animal model of Parkinson's disease: A relationship to behavioral activation

✍ Marinete Pinheiro-Carrera; Carlos Tomaz; Joseph P. Huston; Huiliang Dai; Robert 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 458 KB